ImmunityBio amends stock sale agreement to authorize $460M offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St futures gain on tech rebound, Middle East peace hopes
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil falls 1% as traders digest escalation in US-Iran strikes
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190
- Wall Street indexes fall more than 1%, hit by tech, Iran war worries
Form 424B5 ImmunityBio, Inc.
December 29, 2025 6:02 AM ESTTable of Contents
Filed Pursuant to Rule 424(b)(5)
File No. 333-278770
PROSPECTUS SUPPLEMENT
(To Prospectus dated April 17, 2024)
... More
Form 8-K ImmunityBio, Inc. For: Dec 23
December 29, 2025 6:02 AM ESTfalse 0001326110 0001326110 2025-12-23 2025-12-23... More
